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Abstract
Background: Noninvasive and tissue-specific technologies of gene transfection would be valuable in clinical gene
therapy. This present study was designed to determine whether it could enhance gene transfection in vivo by the
combination of ultrasound-targeted microbubble destruction (UTMD) with polyethylenimine (PEI) in tumor
xenografts, and illuminate the effects of gene silencing and apoptosis induction with short hairpin RNA (shRNA)
interference therapy targeting human survivin by this novel technique.
Methods: Two different expression vectors (pCMV-LUC and pSIREN) were incubated with PEI to prepare cationic
complexes (PEI/DNA) and confirmed by the gel retardation assay. Human cervical carcinoma (Hela) tumors were
planted subcutaneously in both flanks of nude mice. Tumor-bearing mice were administered by tail vein with PBS,
plasmid, plasmid and SonoVue microbubble, PEI/DNA and SonoVue microbubble. One tumor was exposed to
ultrasound irradiation, while the other served as control. The feasibility of targeted delivery and tissue specificity
facilitated by UTMD and PEI were investigated. Moreover, immunohistochemistry analyses about gene silencing
and apoptosis induction were detected.
Results: Electrophoresis experiment revealed that PEI could condense DNA efficiently. The application of UTMD
significantly increases the tissue transfection. Both expression vectors showed that gene expressions were present
in all sections of tumors that received ultrasound exposure but not in control tumors. More importantly, the
increases in transgene expression were related to UTMD with the presence of PEI significantly. Silencing of the
survivin gene could induce apoptosis effectively by downregulating survivin and bcl-2 expression, also cause up-
regulation of bax and caspase-3 expression.
Conclusions: This noninvasive, novel combination of UTMD with PEI could enhance targeted gene delivery and
gene expression in tumor xenografts at intravenous administration effectively without causing any apparently
adverse effect, and might be a promising candidate for gene therapy. Silencing of survivin gene expression with
shRNA could be facilitated by this non-viral technique, and lead to significant cell apoptosis.
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Gene therapy holds great promise for the treatment of
cancer diseases. Successful gene therapy requires safe
and efficient delivery systems [1]. Most viral vectors
pose a potential risk of insertional mutagenesis and
interference responses [2]. Nonviral delivery systems are
safe and easy to apply, but suffer from low transfection
efficiency and transient gene expression [3]. Although
methods such as cationic polymers could enhance the
gene transfection in vitro [1], the results of in vivo stu-
dies were still not so satisfactory because targeting vec-
tors have to overcome chemical and structural barriers
to reach cells [4]. Therefore, non-viral gene transfer has
low efficiency in vivo and transfection with intrave-
nously administered plasmid DNA is difficult [5]. More
recently, in order to elevate the transfection efficiency of
non-viral vector system, microbubble and the sonopora-
tion inducted by ultrasound could be used to increase
t h eu p t a k eo fp l a s m i dD N At a r g e t e d l y[ 6 - 9 ] .U l t r a -
sound-targeted microbubble destruction (UTMD), as a
means of stimulating cell membrane permeabilisation
for the purposes of transferring plasmid DNA or drug
into cells, has offered advantage over viral technologies
[10-12]. When UTMD was combined with cationic poly-
mers or liposome, the gene transfection efficiency had
been markedly improved [4,11,13-16]. However, most
studies with this technology have mainly used reporter
gene to show transfection rather than efficacy in cancer
gene therapy.
Survivin, the smallest member of the mammalian inhi-
bitors of the apoptosis protein (IAP) family [17,18], is
upregulated in various malignancies to protect cells
from apoptosis [18,19], which justifies its role as a
rational target for cancer therapy [20]. RNA interference
(RNAi) is a potent and convenient technique, and is
widely used in the applications such as gene function
analysis [7,21,22]. RNAi mediated survivin knock-down
in different cell lines caused increased apoptosis rates
and cell cycle arrest, reduced viability and clonogenic
survival as well as chemosensitization and radiosensitiza-
tion [20,23,24]. In contrast to chemically synthesized,
sequence-specific double-stranded short interference
RNA (siRNA), short-hairpin RNA (shRNA) expression
vectors could be used to establish stable gene expres-
sion, and could be a powerful tool for anticancer ther-
apy [21,22]. Apoptosis induction by shRNA targeting
survivin represents an efficient, novel strategy for cancer
gene therapy [25-27]. These shRNA expression vectors
could be deliveried by UTMD systems, but related study
was rare [28].
For this purpose, in this present study, gene transfer
of tumor xenografts in nude mice was performed
through intravenous injection using the method of the
combination of UTMD and polyethylenimine (PEI). We
also tested the effects of gene silencing and apoptosis
induction with shRNA interference therapy targeting
human survivin by this novel technique. The result
showed that, transfection efficiency was significantly
improved and provided a new way for in vivo cancer
gene therapy.
Materials and methods
Preparation of Plasmid DNA
pCMV-LUC (7.4 kb) was constructed by cloning the
luciferase gene from the pGL3-Promoter Vector (5.01
kb, Promega Corp., Madison, WI, USA) into pcDNA3.1
(5.42 kb, Invitrogen, San Diego, CA, USA) at the Bam
HI and Hind III sites [29].
The pSIREN-DNR-DsRed-Express Vector (6,7 kb, BD
Biosciences Clontech, USA), was an expression vector
for red fluorescence protein (RFP) gene, which excita-
tion and emission maxima occur at 557 nm and 579
nm, respectively. A shRNA expression vector targeting
human survivin gene (GenBank accession no.
NM_001168) was designed and synthesized as described
previously [28]. The selected reconstructed plasmid for
transfection was extracted and purified using a Qiaquick
Kit (Qiagen, Crawley, UK). The double strand oligos
generating survivin shRNA were subcloned into linear-
ized expression vector at the Bam HI and EcoR Is i t e s .
The specific recombinant shRNA vector was named pSI-
REN-S. Similarly, a non-specific control vector was con-
structed, which was named pSIREN-C.
The concentration of isolated plasmid DNA was
determined by absorbance at 260 nm wavelength (A260)
using UV spectrophotometry (DU-640, Beckman Coul-
ter, Fullerton, CA, USA) and resuspended to a final con-
centration of 1 μg/μl in buffer. In addition, the
absorbance ratio of the A 260 to A 280 was between 1.8
and 2.0, indicating that the purified plasmid DNA was
free of contaminants. The recombinant plasmid was
evaluated by Bio Imaging Systems (Syngene, Synoptics
Ltd, Cambridge, UK).
Preparation of Transfection Complexes
Branched PEI with an average molecular weight of 25
kDa was obtained from Sigma-Aldrich (St. Louis, MO,
USA). An aqueous stock solution of PEI was prepared
by diluting 1 mg of the commercial solution in 1000 ml
DI water, neutralized with HCl and filtering at 0.2 μm
(Millipore, Bedford, MA, USA). Two PEI/DNA com-
plexes were performed by mixing PEI and plasmids at
1:4 to 8:1 of N/P ratio [PEI nitrogen: DNA phosphate
r a t i o ,b a s e do nt h er e c o g n i t i o nt h a t1μl of PEI
stock solution contains 10 nmol of amine nitrogen
and 1 μgo fD N Ac o n t a i n s3n m o lo fp h o s p h a t e[ 3 0 ] ] .
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perature and stored in 4°C. Electrophoresis was carried
out for 40 min at 80 V. The separations were visualized
to determine the optimal ratio of PEI/DNA complexes.
The suspension of SonoVue microbubbles (Bracco
Research, Switzerland) were reconstituted before use by
injecting 5 mL of 0.9% saline solution. Before the experi-
ments, plasmid DNA (30 μg) or PEI/DNA complexes
and SonoVue microbubble (100 μL) were gently agitated
with phosphate buffered saline (PBS) to a final volume
of 200 μL to prepare the transfection complexes (P/
SonoVue and P/SonoVue/PEI, P indicated as plasmid)
as detailed previously [11]. All the complexes were pre-
pared by incubation for 15 min at room temperature.
Cell Culture
Human cervical cancer cell lines (HeLa) were obtained
from China Center for Type Culture Collection
(CCTCC) and incubated in Dulbecco’s modified Eagle’s
medium (DMEM, Gibco, USA) with 10% fetal bovine
serum (FBS, Gibco, USA) and 100 U/ml penicillin, 100
μg/ml streptomycin, at 37°C in a humidified environ-
ment of 5% CO2 and 95% air. Total cell count was
determined with a hemocytometer (Burker Turk). Initial
cell viability was determined by means of exclusion with
trypan blue dye (Sigma-Aldrich, USA). Exponentially
growing cells were used in all experiments. Before ani-
mal modeling, Hela cells were harvested, collected and
centrifuged, and then resuspended in 100 μlD M E Mt o
prepare single cell suspension.
Animal Protocol
Female Balb/c (nu/nu) mice, 4-6 week old, weighing
15-21 g, were purchased from experimental animal
research center. All the mice were treated and housed
according to approved guidelines (Guidelines for the
Care and Use of Laboratory Animals).
The mice were fixed on superclean bench according
to the principle of aseptic operation, and inoculated sub-
cutaneously into the flank with 2 × 10
6 cells per mouse
after local sterilized. The mice were continued to be
raised at specified pathogen free (SPF) qualification after
operation, being observed one time every two days. Two
weeks later, the experiments were initiated when the
tumors reached a size of 5-10 mm.
Experimental Grouping of Gene Delivery
To analyze the impact of the combination of UTMD
and PEI on the RFP expression, nude mice bearing
tumor xenografts were selected, randomly divided into
f o u rg r o u p s ,f o u rm i c ee a c hg r o u p :Ag r o u p :P B Sg r o u p
(negative control); B group: naked pSIREN-C group; C
group: pSIREN-C/SonoVue group; D group: pSIREN-C/
SonoVue/PEI group.
To investigate the effect of UTMD combined with PEI
on the luciferase activity, another 20 nude mice were
selected, randomly divided into five groups, four mice
each group, a group; PBS group (negative control);
b group: naked pCMV-LUC group; c group: pCMV-
LUC/SonoVue group; d group: pCMV-LUC/SonoVue/
PEI group; e group: after the injection of pCMV-LUC/
SonoVue/PEI complexes, the tumor xenografts were not
received ultrasound irradiation and compared with
group d to understand the impacts of this transfection
method and ultrasound irradiation on other non-target
organs (livers, kidneys, lungs, hearts). In other groups,
only one side of the tumor xenografts was received irra-
diation, while the other served as control.
The total dose of injection was 200 μl, and the plas-
mid dosage was 30 μg/mouse. The microbubbles were
mixed with plasmid solution or PEI/DNA complex at
the proportion of 1:1. All the plasmid DNA or com-
plexes were administrated by tail vein. The mice were
anesthetized by diethylether and fixed on the flats. The
tumor xenografts were subsequently sonicated by a
transducer (Accusonic, Metron Medical Australia Pty.
Ltd.) placed on the skin with contact gel (Aquasonic
100, Parker Laboratories Inc., USA). Ultrasound para-
meters were set at 3 MHz, 2 W/cm
2, 2 min, duty cycle
20%. During the exposure, the ultrasound transducer
was moved around in a circular motion to ensure the
whole tumor xenograft exposed.
Analysis of Transfection Efficiency
3 days after ultrasound treatment [9], nude mice were
sacrificed by cervical dislocation. The specimens of
tumor xenografts, the skins around the tumors, hearts,
livers and lungs, were immediately harvested, embedded
in optimal cutting temperature compound (OCT, Tis-
sue-Tek, Sakura Finetek, Torrance, CA, USA), and
stored at -80°C until further analyses. Cross sections (10
μm-thick slices) were cut with a cryostat (CM1900,
Leica, Germany) and affixed to glass slides. Fluorescence
expression and distribution pattern were observed with
confocal laser microscopy (Fluoview FV500, Olympus,
Japan). Digital image subtraction method was devised to
eliminate autofluorescence. Slices were coded so that
analyses were performed without knowledge of which
treatment each individual animal had received. For each
sample, RFP expression and transfection efficiency were
evaluated in six randomly chosen fields per section.
For examination of luciferase reporter gene expres-
sion, tumor xenografts and the non-targeted organs in
group d and e were removed and homogenized, frozen
in liquid nitrogen, and stored at -80°C. Luciferase activ-
ity in the tissue lysate was measured using a Lumat
LB9507 instrument (Berthold, Bad Wildbad, Germany).
Luciferase background (100-200 RLU) was subtracted
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RLU/organ or RLU/tumor [31]. One million RLU corre-
spond approximately to 2 ng luciferase.
Gene Silencing and Apoptosis Induction Effects of shRNA
Expression Vector Targeting Survivin Transfected by
UTMD and PEI
A total of 18 mice were randomly divided into 3 experi-
mental groups, 6 mice each group. Control group, mice
were received injections of PBS; pSIREN-S +UTMD
group, mice were received injections of pSIREN-S/Sono-
Vue and followed by local ultrasound irradiation; pSI-
REN-S + UTMD + PEI group, mice were received
injections of pSIREN-S/SonoVue/PEI complexes and fol-
lowed by local ultrasound irradiation. All injections were
performed with the plasmid DNA dose of 30 μg/mouse.
The number of dead mice was noted every day. 21 days
after injection, the tumor-bearing mice were humanely
sacrificed and the solid tumors were harvested.
Immunohistochemistry
The samples were fixed with formaldehyde, dehydrated
with a graded alcohol series, and embedded in paraffin.
The sections were incubated with primary antibodies
against survivin, bcl-2, bax and caspase-3 (1:100 dilution,
Santa Cruz Biotechnology) and then incubated with
appropriate biotinylated secondary antibody as detailed
previously [32]. The colorimetric detection was per-
formed by using a DAB detection kit (Boster Biological
Technology Co. Ltd., Wuhan, China). Images were
acquired with a microscope (BX51, Olympus, Japan).
The assessment of the immunohistochemical results
were modified from that described previously [33,34].
The percentage of cells expressing the marker were clas-
sified qualitatively based on the intensity of staining and
the percent of cells as follows: score 1: no reactivity;
score 2: low intensity staining in less than 10% of cells;
score 3: low to moderate intensity staining in 11% to
30%; score 4: moderate to strong staining in 31% to
50%; score 5: diffuse, strong intensity staining in 50%.
Histopathology
Serial sections of tumor tissue were processed for routine
histological examination. The specimens were washed
with PBS to remove blood, fixed with formaldehyde,
dehydrated with a graded alcohol series, and embedded
in paraffin. Hematoxylin eosin staining (H&E) was per-
formed on the specimens, for histopathologic evaluation
of hemorrhage, necrosis, and inflammation.
Statistical Analysis
Statistical analyses were performed by the SPSS 13.0
software package (SPSS, Inc, Chicago, IL). All values
were expressed as mean ± SD. Analysis of variance with
t test and analysis of variance (ANOVA) test were used
to determine the significance of the difference in a mul-
tiple comparison. If the ANOVA was significant, the
Tukey’s procedure was used as a post hoc test. Differ-
ences with a P v a l u eo fl e s st h a n0 . 0 5w e r ec o n s i d e r e d
to be statistically significant.
Results
Identification of pCMV-LUC by Restriction Enzymes
Digestion
After double-enzyme cutting by Bam HI and Hind III,
the restriction enzymes digestion results showed that
the objective fragment of the pCMV-LUC plasmid could
be detected at around 2000 bp, which was exactly coin-
cidence with the size of the designed DNA (Figure 1).
Gel Retardation Analysis of PEI/DNA Complexes
Agarose gel electrophoresis analysis showed that (Figure
2), with the increase of N/P ratio of PEI/DNA com-
plexes, the plasmid DNA migrated more slowly. When
N/P ≥ 3, the plasmid DNA migration could not be
Figure 1 Identification of pCMV-LUC by restriction enzymes
digestion. 1, Marker, 1 kb ladder; 2, pCMV-LUC; 3, pCMV-LUC/Hind
III + Bam HI; the plasmid pCMV-LUC or with the restriction enzymes
digestion showed two bands after electrophoresis. A correct
insertion was showed a band of 2000 bp (as arrowhead indicated)
cut off by Hind III and Bam HI.
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charge remained in the hole. PEI could effectively con-
densate the plasmid DNA, and the electrophoresis ana-
lyses of both plasmids were similar (Figure 2A-B).
According to the results of electrophoresis, the N/P
ratio was chose for 6 in this study and used in the fol-
lowing experiments.
Enhanced RFP Expression in Transplanted Tumors by
Combination of UTMD and PEI
Regardless of ultrasound irradiation, there was no
obvious RFP expression in Group A and B (Figure 3A-B).
Without ultrasound irradiation, there were only a few
cells expressing RFP in pSIREN-C/SonoVue group and
red fluorescent signal was weak in the majority of sam-
ples (Figure 3C). However, the RFP expression was
enhanced and increased when the injection of plasmid
DNA and SonoVue combined with ultrasound irradiation
(Figure 3D), but it was still weaker than that of pSIREN-
C/SonoVue/PEI group (Figure 3E). When UTMD
combined with PEI, RFP expression was increased signifi-
cantly with strong density and signal (Figure 3F).
Enhanced Luciferase Activity by Combination of UTMD
and PEI
The luciferase expression could not be increased by
ultrasound irradiation after the injection of naked plas-
mid (t = -2.174, P=0.095, Figure 4). Without ultrasound
exposure, microbubble could not significantly improve
the luciferase activity of tumor tissues. But the
application of UTMD could significantly promote the
transfection efficiency (t = -11.433, P <0 . 0 1 ) ,w i t ht h e
luciferase expression increased by about 14 fold.
The transfection efficiency was the highest when
UTMD combined with PEI. As compared with non-
irradiated tumor, the luciferase activity of irradiated sam-
ples has increased by about 10 fold (t = -11.633, P < 0.01).
And the luciferase expression increased by about 111 fold
w h e nc o m p a r e dw i t ht h a to fn o n - c o m b i n e dP E Ig r o u p
(P < 0.01). This demonstrated that the combination of
UTMD with PEI would significantly facilitate the transfec-
tion efficiency.
Figure 2 Electrophoretic patterns of plasmid DNA complexes
prepared with PEI at various N/P ratios: N/P ratio = PEI
nitrogen/DNA phosphate; (A) pCMV-LUC, (B) pSIREN-S. Lanes
1-10: the N/P molar ratios of 1/4, 1/2, 1, 3/2, 2, 5/2, 3, 4, 6, and 8.
Figure 3 Fluorescent microphotographs of the tumor
xenografts in nude mice after intravenous injection of naked
pSIREN-C (A, B), pSIREN-C/SonoVue complex (C, D) and pSIREN-
C/SonoVue/PEI complex (E, F) with or without ultrasound
irradiation. Ultrasound irradiation parameters were as follow,
irradiation time = 2 min, intensity = 2 W/cm
2, frequency = 3 MHz,
and duty cycle = 20%. UTMD = ultrasound targeted microbubble
destruction; PEI = polyethylenimine; bar = 100 μm.
Figure 4 Luciferase expressions of tumor xenografts in nude
mice with UTMD and PEI. Control: non ultrasound exposure; P:
pCMV-LUC; in the same condition (control or ultrasound exposure),
as compared with PBS group, *P<0.01; as compared with P group,
†P < 0.01; as compared with P/SonoVue group,
‡P < 0.01; as
compared with control group,
§P<0.01.
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A ss h o w ni nF i g u r e5 ,w h e nt h et u m o rx e n o g r a f t sw a s
irradiated (group d), the increase extent of luciferase activ-
ity was significantly higher than that of non-irradiated
tumor and other tissues and organs (all P < 0.01). Livers,
lungs, kidneys and hearts in group d, e, had relative low
luciferase activity level, but all were lower than that of the
tumor xenografts (P < 0.01). The ultrasound irradiation of
the transplanted tumors had no evident impact on other
organs (P > 0.05).
Degradation of Survivin Was the Main Trigger for
Apoptosis Induction in Nude Mice
A ss h o w ni nF i g u r e6 A ( a - b )a n d6 B ,t h em i c r o s c o p i c
examination of stained tumor sections showed that the
score of survivin expression in control group and pSI-
REN-S +UTMD group were significantly higher than that
of pSIREN-S + UTMD + PEI group (both P <0 . 0 1 ) .
Comparing with that of control and pSIREN-S + UTMD
group, the score of bcl-2 protein expressions in pSIREN-
S + UTMD + PEI group also resulted in downregulation
markedly (both P < 0.01, Figure 6A(c-d) and 6B). More-
over, As shown in Figure B, score of bax [Figure 6A(e-f)]
and caspase-3 [Figure 6A(g-h)] protein expressions in
pSIREN-S + UTMD + PEI group was upregulated
remarkably as comparing with control group and pSI-
REN-S + UTMD group (all P < 0.01, Figure 6B).
Histology Examination
In pSIREN-S + UTMD + PEI group, H&E staining
showed that the integrities of tumor xenografts were
good. The histologic structure of livers, kidneys, lungs,
hearts and other organs were normal, and no necrosis
or fibrosis changes were seen. Moreover, the results
showed no abnormalities such as inflammation or
degeneration in any tissues.
Discussion
PEI, as one of the most effective poly-cationic gene vec-
tors, could condense plasmids DNA into cationic poly-
mers, protect the plasmids against being degraded by
nucleinase or enzymes within a few hours, and enhance
the endocytosis of plasmids DNA, thus promoting gene
transfection in vivo [31,35]. On the other hand, ultra-
sound could increase transfection efficiency in vivo and
in vitro. Microbubbles could significantly improve the
transgenic expression. Moreover, ultrasonic energy
c o u l db ef o c u s e do nt h et a r g e ts i t eo fg e n et r a n s f e rb y
local irradiation [11]. It was particularly important for
gene transfer in deep tissues. A lot of literature
[13-16,36] reported that the combination of cationic
Figure 5 Luciferase expressions of non-target organs in nude
mice with UTMD and PEI. P: pCMV-LUC; as compared with non-
irradiated tumors, *P < 0.01; as compared with other organs,
†P<0.01; as compared with P/SonoVue/PEI complexes injection
alone,
‡P>0.05.
Figure 6 Apoptosis induction by downregulation of survivin in
nude mice. (A) P: pSIREN-S; Representative expressions of survivin
(a and b), bcl-2 (c and d), bax (e and f) and caspase-3 (g and h)
protein were shown. Positive expressions in serial sections were
shown in representative photomicrographs (positive stain was
brown). Magnification = 400×. (B) The scores were classified as 1 to
5, based on the intensity of staining and the percent of positive
expression cells. The results indicated that inhibition of survivin by
administration of shRNA plasmid by UTMD technique resulted in
apoptosis induction by downregulating bcl-2 and survivin
expression, and upregulating the activity of caspases-3 and bax.
Furthermore, the combination of UTMD and PEI could lead to the
most significant gene downregulation and cell apoptosis. *P<0.001
vs control, †P<0.001 vs P+UTMD group.
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efficiency. Lawrie et al. [13] reported that UTMD
enhanced approximately 300 fold increments in trans-
gene expression after naked DNA transfection. While
UTMD and polyplex yielded transgene expression levels
approximately 3000 fold higher than after naked DNA
alone. Anwer et al. [14] reported that UTMD resulted
in a significant increase in gene transfer to the tumors
by the tail vein injection and the maximum of expres-
sion was 270-fold. In this study, when the application of
UTMD combined with PEI, the transfection efficiency
for both plasmids in the tumor xenografts could be sig-
nificantly improved, providing a new strategy for cancer
gene therapy.
UTMD could facilitate targeted gene therapy, thus sig-
nificantly enhance gene transfection in vivo.T h er e s u l t s
of our study showed that, after intravenous injection of
plasmids DNA, there was obvious gene expression in
the irradiated tumors. And the difference had statistical
significance when compared with that of non-irradiated
tumors. Similar to our study, Haag et al. [37] established
two tumors in each animal, injected the ODN-loaded
microbubbles intravenously, and then exposed only one
of the tumors to ultrasound. Their results showed that,
digoxigenin staining intensity was significantly stronger
in treated tumors (16-49%) that were exposed to ultra-
sound as compared with the untreated collateral control
tumors (2-18%). Dittmar et al. [38] applied pulsed high
intensity focused ultrasound to expose one tumor while
the other tumor served as a control and found that local
exposure in tumors could enhance expression of green
fluorescent protein (GFP). Moreover, UTMD could
transduce plasmids into target tissue when systemic
administration rather than direct target organ delivery
by catheter-based approaches or operative injection.
And this was particularly important in cardiovascular as
well as gene therapy of inaccessible tumors. Howard
et al. [39] reported that, systemic delivery of Ad-GFP
microbubbles pretreated with complement and injected
in the tail vein of nude mice resulted in high level of
transgene within the tumor alone. Both fluorescence
microscopy and GFP immunohistochemistry demon-
strated UTMD induced specific transduction in the tar-
geted cells only, with no uptake in hearts, lungs or liver.
Chen et al. [2] incorporated plasmids into the phospho-
lipid shell of gas-filled microbubbles, which were then
infused into rats and destroyed within the pancreatic
microcirculation with UTMD technology. They found
that UTMD allowed relatively noninvasive delivery of
genes to pancreatic islets with efficiency sufficient to
modulate the function of b-cell, and a low level of luci-
ferase activity was detected in all organs within the
ultrasound beam. Activity of skeletal muscle or right
kidney which lie outside the ultrasound beam was not
detected in their study. This data illustrated that this
technique largely could prevent the problem of hepatic
uptake seen with viral vectors. Moreover, study indi-
cated [9] that the reticuloendothelial system was not a
limiting factor for the ultrasound-based gene delivery
with these experimental conditions. While Huber et al.
[5] found that, after intratumoral DNA injection, ultra-
sound induced a 10-fold increase of b-galactosidase
positive cells. In contrast, ultrasound was not found to
enhance reporter gene expression after intravenous plas-
mid application. But they did not apply the UTMD
technology.
To further enhance the transfection efficiency of
UTMD, DNA can be protected by the complexation of
cationic polymers and microbubbles. Because both
membrane of SonoVue microbubble and plasmid DNA
bear a net negative charge [40], the binding of plasmid
DNA and microbubbles are likely to be weak and transi-
ent. Cationic polymers, such as PEI, have strong capacity
to bind to negatively charged DNA and proteins. It was
hypothesized that P/PEI complexes were adsorbed to
the surface of microbubbles through electrostatic inter-
action, and P/SonoVue/PEI complexes were formed.
T h ec o m p l e x e sc o u l db er e l e a s e dt a r g e t e d l yb yu l t r a -
sound irradiation. In addition, ultrasound irradiation
could enhance gene transfection of tumors as well, and
reduce gene expression of other non-target organs.
SonoVue microbubbles could significantly increase the
transfection efficiency, but further study was still needed
to validate the specific mechanisms.
Just like the study of Gao et al. [41], 3 MHz ultra-
sound in our study facilitated the irradiation of superfi-
cial tumor xenografts. Ultrasonic energy was more
focused, and had no significant impacts on other
organs. As the N/P ratio increased, the toxicity will be
grater, too [31]. The results indicated that this N/P
ratio in our experiment could enhance in vivo transfec-
tion efficiency effectively. But it was still need to
further analysis and different N/P ratio should be com-
pared. In addition, the transfection efficiency is related
to the cell line, microbubble components and DNA
vectors. Blood supply or reaction to some certain gene
was different, the effects would be different. Moreover,
tumor growth was very rapid in the cells with higher
division rate, and cell proliferation would dilute the
effect of transfection. It would lead to elimination of
exogenous plasmid DNA from transfected cells [42].
Furthermore, there are lots of differences in the opti-
mal time points among different organs and tissues,
the transfection efficiency will differ for different
administration ways, too. Therefore, studies of the opti-
mization analysis of different methods of transfection
mediated by the combination of UTMD and PEI
should be further investigated.
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tors of the apoptosis protein (IAP) families. Cancer cells
possess defects in apoptotic, with the consequence of
increased resistance to cell death. From the human
cancer gene therapy perspective, using molecular
antagonists of survivin was one approach which was
regarded as a predominant strategy in anticancer ther-
apy for enhancing cancer cell death [25-27]. On the
o t h e rh a n d ,f o rt h ep o t e n t i a lu s eo fU T M Da sat h e r a -
peutic gene delivery system, it is critically important to
investigate the apoptosis induction under actual physio-
logical conditions. Diverse molecular mechanisms have
been implicated in the apoptosis induction [43,44]. The
bcl-2 family of proteins regulates various steps in apop-
tosis and blocks cell death, whereas pro-apoptotic pro-
teins such as bax promote apoptosis [33,34]. Caspase-3
is the ultimate executioner caspase that is essential for
the nuclear changes associated with apoptosis [45].
Moreover, survivin is known to directly or indirectly
interact with caspase-3 and subsequently inhibit its
activity. In our study, microscopic examination and
scoring showed that protein expressions of bax and cas-
pase-3 were up-regulated in P+PEI+UTMD group as
compared with those of control group or P+UTMD
group, while protein expressions of survivin and bcl-2
were down-regulated markedly. The data indicated that
the inhibition of survivin by administration of shRNA
expression vectors with the combination of UTMD and
PEI resulted in apoptosis induction in nude mice by
downregulating bcl-2 expression and upregulating the
activity of bax and caspases-3.
Conclusions
In summary, UTMD could synergistically promote the
development and application of other gene transfer
methods in vivo. It could be used as a safe and effective
non-viral gene delivery system. The combination of
UTMD and PEI, which could significantly enhance the
gene expression of plasmid DNA in the tumor tissue,
was a new method of in vivo gene transfer with a good
prospect. Survivin downregulation with shRNA expres-
sion vector mediated by the UTMD and PEI technique
could obviously induce apoptosis in vivo.T h i sm e t h o d
will provide a noninvasive, safe, promising candidate for
tumor gene delivery. More researches are needed to
further the efficient, promising novel technique for can-
cer gene therapy.
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